|
1
|
Le Rhun E, Weller M, Brandsma D, Van den
Bent M, de Azambuja E, Henriksson R, Boulanger T, Peters S, Watts
C, Wick W, et al EANO Executive Board and ESMO Guidelines
Committee, : EANO-ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up of patients with leptomeningeal metastasis
from solid tumours. Ann Oncol. 28 (Suppl 4):iv84–iv99. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chamberlain MC: Leptomeningeal metastasis.
Curr Opin Oncol. 22:627–635. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roth P and Weller M: Management of
neoplastic meningitis. Chin Clin Oncol. 4:262015.PubMed/NCBI
|
|
4
|
Le Rhun E, Taillibert S and Chamberlain
MC: Carcinomatous meningitis: Leptomeningeal metastases in solid
tumors. Surg Neurol Int. 4 (Suppl 4):S265–S288. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gleissner B and Chamberlain MC: Neoplastic
meningitis. Lancet Neurol. 5:443–452. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van der Ree TC, Dippel DW, Avezaat CJ,
Sillevis Smitt PA, Vecht CJ and van den Bent MJ: Leptomeningeal
metastasis after surgical resection of brain metastases. J Neurol
Neurosurg Psychiatry. 66:225–227. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hust MH and Pfitzer P: Cerebrospinal fluid
and metastasis of transitional cell carcinoma of the bladder. Acta
Cytol. 26:217–223. 1982.PubMed/NCBI
|
|
8
|
Mandell S, Wernz J, Morales P, Weinberg H
and Steinfeld A: Carcinomatous meningitis from transitional cell
carcinoma of bladder. Urology. 25:520–521. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hussein AM, Savaraj N, Feun LG, Ganjei P
and Donnelly E: Carcinomatous meningitis from transitional cell
carcinoma of the bladder: Case report. J Neurooncol. 7:255–260.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bishop JR Jr, Moul JW, Maldonado L and
McLeod DG: Transitional cell carcinomatous meningitis after M-VAC
(methotrexate, vinblastine, doxorubicin, and cisplatin)
chemotherapy. Urology. 36:373–377. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raghavan D and Chye RW: Treatment of
carcinomatous meningitis from transitional cell carcinoma of the
bladder. Br J Urol. 67:438–440. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eng C, Cunningham D, Quade BJ, Schwamm L,
Kantoff PW and Skarin AT: Meningeal carcinomatosis from
transitional cell carcinoma of the bladder. Cancer. 72:553–557.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Santarossa S, Vaccher E, Balestreri L,
Volpe R and Tirelli U: Solitary meningeal recurrence in a patient
with transitional cell carcinoma of the bladder with locally bulky
disease at presentation. J Neurooncol. 35:141–143. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cozzarini C, Reni M, Mangili F, Baldoli
MC, Galli L and Bolognesi A: Meningeal carcinomatosis from
transitional cell carcinoma of the bladder: Report of two cases and
review of the literature. Cancer Invest. 17:402–407. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Isaka T, Maruno M, Sato M, Kinoshita M,
Nishida T, Kiyohara H and Yoshimine T: Brain metastasis from
small-cell neuroendocrine carcinoma of the urinary bladder: A case
report. Brain Tumor Pathol. 19:117–122. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bruna J, Rojas-Marcos I, Martínez-Yelamos
S, Català I, Vidaller A, Galán C, Krupinski J and Rubio F:
Meningeal carcinomatosis as the first manifestation of a
transitional cell carcinoma of the bladder. J Neurooncol. 63:63–67.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sugimori K, Kobayashi K, Hayashi M, Sakai
N, Sasaki M and Koshino Y: Leptomeningeal carcinomatosis from
urinary bladder adenocarcinoma: A clinicopathological case study.
Neuropathology. 25:89–94. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uncu D, Arpaci F, Beyzadeoglu M, Gunal A,
Surenkok S, Ozturk M and Ozet A: Meningeal carcinomatosis: An
extremely rare involvement of urinary bladder carcinoma. Tumori.
96:352–354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bowen CD, Von Burton G, Bargen RC, Madonia
P, Zhang S, Toledo EG, Zweig R and Pant C: Carcinomatous meningitis
secondary to transitional cell bladder cancer. South Med J.
103:809–812. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Butchart C, Dahle-Smith A, Bissett D,
Mackenzie JM and Williams DJ: Isolated Meningeal Recurrence of
Transitional Cell Carcinoma of the Bladder. Case Rep Oncol.
3:171–175. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zada G and Chen TC: A novel method for
administering intrathecal chemotherapy in patients with
leptomeningeal metastases and shunted hydrocephalus: case report.
Neurosurgery. 67:onsE306–307. 2010.PubMed/NCBI
|
|
22
|
Kastritis E, Zagouri F, Dimopoulos MA and
Papadimitriou CA: Carcinomatous meningitis from transitional cell
carcinoma of the urinary bladder. J BUON. 16:373–374.
2011.PubMed/NCBI
|
|
23
|
Tadepalli S, Coleman T, Hacket LA and
Liles GB: Carcinomatous meningitis: The natural history of
successfully treated metastatic bladder cancer. Case Rep Oncol.
4:406–412. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Molek KR, Seili-Bekafigo I, Štemberger C,
Jonjić N, Đordević G and Duletić-Načinović A: Plasmacytoid
urothelial carcinoma - diagnostic challenge in cytology. Diagn
Cytopathol. 41:369–373. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yust-Katz S, Mathis S and Groves MD:
Leptomeningeal metastases from genitourinary cancer: The University
of Texas MD Anderson Cancer Center experience. Med Oncol.
30:4292013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Swallow TW, Mabbutt S and Bell CR: Muscle
invasive bladder cancer culminating with leptomeningeal
carcinomatosis. Can Urol Assoc J. 9:E903–E904. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Teyssonneau D, Daste A, Dousset V,
Hoepffner JL, Ravaud A and Gross-Goupil M: Metastatic non-muscle
invasive bladder cancer with meningeal carcinomatosis: Case report
of an unexpected response. BMC Cancer. 17:3232017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Alfred Witjes J, Lebret T, Compérat EM,
Cowan NC, De Santis M, Bruins HM, Hernández V, Espinós EL, Dunn J,
Rouanne M, et al: Updated 2016 EAU Guidelines on Muscle-invasive
and Metastatic Bladder Cancer. Eur Urol. 71:462–475. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu PF, Lin CH, Kuo CH, Chen WW, Yeh DC,
Liao HW, Huang SM, Cheng AL and Lu YS: A pilot study of bevacizumab
combined with etoposide and cisplatin in breast cancer patients
with leptomeningeal carcinomatosis. BMC Cancer. 15:2992015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zagouri F, Sergentanis TN, Bartsch R,
Berghoff AS, Chrysikos D, de Azambuja E, Dimopoulos MA and Preusser
M: Intrathecal administration of trastuzumab for the treatment of
meningeal carcinomatosis in HER2-positive metastatic breast cancer:
A systematic review and pooled analysis. Breast Cancer Res Treat.
139:13–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gion M, Remon J, Caramella C, Soria JC and
Besse B: Symptomatic leptomeningeal metastasis improvement with
nivolumab in advanced non-small cell lung cancer patient. Lung
Cancer. 108:72–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Massari F, Di Nunno V, Cubelli M, Santoni
M, Fiorentino M, Montironi R, Cheng L, Lopez-Beltran A, Battelli N
and Ardizzoni A: Immune checkpoint inhibitors for metastatic
bladder cancer. Cancer Treat Rev. 64:11–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
